NABL | ICMR Accredited Lab | ICMR Reg. No.: CNCPLDD
powered by | 7519071907


What is the purpose of a tdt lymphoma test?

The purpose of a TDT lymphoma test is to diagnose lymphoma, a type of cancer that affects the lymphatic system. TDT, or terminal deoxynucleotidyl transferase, is an enzyme that is present in immature lymphocytes. The test measures the level of TDT in a sample of lymphatic tissue or blood to determine if abnormal lymphocytes are present, which can indicate lymphoma. This test can help with the diagnosis and treatment of lymphoma, as well as monitoring the progression of the disease. The TDT lymphoma test has revolutionized the way lymphoma is diagnosed and treated, making it easier for doctors to accurately identify the type of lymphoma a patient has and determine the most effective treatment plan.

Before the TDT lymphoma test, diagnosing lymphoma was a complex and time-consuming process. Doctors would have to rely on a combination of different tests and scans, including blood tests, biopsies, and CT scans, to determine if a patient had lymphoma and what type it was.

Now, with the TDT lymphoma test, doctors can get a more accurate diagnosis in a shorter amount of time. The test is non-invasive, making it a less painful and stressful experience for patients. It also allows doctors to monitor the progression of the disease and adjust treatment plans accordingly.

The TDT lymphoma test has also led to new advancements in lymphoma research. Scientists are now able to study the molecular and genetic characteristics of lymphoma cells, which has led to the development of new targeted therapies that can more effectively treat the disease.

Overall, the TDT lymphoma test has had a significant impact on the diagnosis and treatment of lymphoma. It has made the process of diagnosing the disease faster, more accurate, and less painful for patients, while also leading to new advancements in lymphoma research and treatment.

How is a tdt lymphoma test conducted?

A tdt lymphoma test is usually conducted by obtaining a small sample of tissue from the lymph nodes or bone marrow. This sample is then sent to a laboratory where it is analyzed for the presence of TDT (terminal deoxynucleotidyl transferase) enzyme. TDT is an enzyme that is present in the early stages of the development of lymphocytes, a type of white blood cell. Its presence indicates that the lymphoma may be of a type that originates from immature lymphocytes. The test may also involve other diagnostic procedures, such as imaging tests or blood tests, to help determine the extent and location of the lymphoma. The results of the test can provide important information about the type and stage of the lymphoma, which can help guide treatment decisions.

What are the results of a tdt lymphoma test?

A TDT lymphoma test is a diagnostic test that helps in detecting T-cell lymphoma, a type of cancer that affects the white blood cells. The result of the test depends on the levels of the enzyme terminal deoxynucleotidyl transferase (TDT) in the lymphoma cells.

If the TDT levels are high, it indicates that the lymphoma cells are immature and rapidly dividing, which is a characteristic of T-cell lymphoma. On the other hand, if the TDT levels are low or absent, it suggests that the lymphoma cells are mature and slow-growing, which is not typically seen in T-cell lymphomas.

In summary, a positive result (high TDT levels) on a TDT lymphoma test suggests the presence of T-cell lymphoma, while a negative result (low or absent TDT levels) suggests the absence of T-cell lymphoma. However, the test results should always be interpreted in conjunction with other diagnostic tests and clinical findings to arrive at an accurate diagnosis and appropriate treatment plan.

How often should a tdt lymphoma test be performed?

The frequency of T-cell lymphoma tests depends on various factors such as the patient's medical history, overall health, and response to treatment. However, as a general rule, it is recommended to have regular check-ups and repeat TDT lymphoma tests every few months to monitor the progression of the disease. It is crucial to follow your doctor's advice and get tested as per their recommendations to ensure timely diagnosis and treatment. Additionally, if you experience any symptoms or changes in your health, it is recommended to consult your physician and get tested as soon as possible.

What should a patient know before taking the TDT Lymphoma Test?

Before taking the TDT Lymphoma Test, a patient should know that this is a diagnostic test used to detect lymphoma, a type of cancer that affects the lymph system. The test is typically performed on a biopsy sample taken from a lymph node or other affected tissue.

It is important for the patient to understand that the TDT Lymphoma Test is just one of several diagnostic tools that healthcare professionals use to detect and diagnose lymphoma. Other tests such as imaging scans, blood tests, and bone marrow biopsies may also be needed to confirm a diagnosis.

The TDT Lymphoma Test is a highly sensitive test that can detect very small amounts of lymphoma cells. However, it is not 100% accurate and false positive or false negative results can occur. Patients should discuss the limitations and potential risks of the test with their healthcare provider before deciding to proceed with it.

It is also important for patients to understand that a positive test result does not necessarily mean they have lymphoma. Further testing and evaluation by a healthcare provider is needed to confirm a diagnosis and develop an appropriate treatment plan.

Finally, patients should be aware of the potential side effects of any follow-up testing or treatment they may need to undergo if a lymphoma diagnosis is confirmed. They should discuss these risks with their healthcare provider and ask any questions they may have about their care.

Description- This is used in subtyping of blastic leukemia. It is positive in all acute lymphoblastic leukemia (ALL) except Burkitt and B-cell FAB L-3; and in lymphoblastic crisis of chromic myelogenous leukemia (CML-BC-ALL) and lymphoblastic lymphoma. Some nonlymphocytic leukemias also express positivity but there is less intensity and greater variability.

Methodology: Immunohistochemistry

TAT: 3-5 days

Specimen Preparation
Collect - tissue /or cell
Specimen Preparation- formal fix (10 % neutral buffered formalin) and paraffin enter specimen (FFPE specimens square measure needed). shield paraffin block or slides from uncontrolled heat. Transport tissue block or five unstained (3-micron thick sections), charged slides during a tissue transport kit. (Min: a pair of slides). If causing precut slides, don't over heat it.
Storage/Transport Temperature- At temperature or cold. Transport it in cooled instrumentation throughout weather.
Unacceptable conditions- i) Specimens submitted with non-marked/tagged tissue sort square measure rejected.
ii) Depleted specimens aren't tested.
Stability- i) Ambient: Indefinitely;
ii) Refrigerated: Indefinitely;
iii) Frozen: Unacceptable


Get Report In
Pre-Test Information
Home Collection-
Offer PriceN/A
Total AmountN/A
*inclusive of all the taxes, fees and subject to availability

Best Health Checkup Packages